Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection
Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dirk H. Busch(German Center for Infection Research), Florian Voit(Technical University of Munich), Michael Neuenhahn(Institute of Medical Microbiology and Hygiene), Simon Grassmann(Technical University of Munich), Philipp Lückemeier(Institute of Medical Microbiology and Hygiene), Christopher R. Clouser(Max Planck Institute for Plant Breeding Research), Sebastian Jarosch(Boehringer Ingelheim (Germany)), Enzo Nio(ENPICOM (Netherlands)), Joel Eggert(Emory University), Veit R. Buchholz(German Cancer Research Center), Lorenz Mihatsch(Institute of Medical Microbiology and Hygiene), Georg Dössinger(Institute of Medical Microbiology and Hygiene), Lisa Borkner(Trinity College Dublin), Jennifer D. Oduro(Helmholtz Centre for Infection Research), Thomas Müller(Johns Hopkins University), Ludger Klein(Ludwig-Maximilians-Universität München), Lorenzo F. Fanchi(The Netherlands Cancer Institute), Patrick Hoffmann(Luxembourg Institute of Health), Aditya Radhakrishnan, Luka Čičin‐Šain(German Center for Infection Research), Justin Leube(Institute of Medical Microbiology and Hygiene), Bianca Weißbrich(Institute of Medical Microbiology and Hygiene)
Cited by 119
Related Papers
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551